2018
DOI: 10.1080/17512433.2018.1537122
|View full text |Cite
|
Sign up to set email alerts
|

A spotlight on the role, use, and availability of codeine and the implications faced

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
7
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 16 publications
(7 citation statements)
references
References 14 publications
0
7
0
Order By: Relevance
“…21 While prescribers may view these so-called weak opioids as safer alternatives, data suggests that both codeine and tramadol have the potential for misuse and life-threatening adverse effects. 22,23,24 A possible explanation for these differences in prescribing is that, during the study period, low-dose codeine was available over the counter in Canada. Further, tramadol is still not considered a controlled or scheduled substance in Canada; however, it became a controlled substance in 2007 in Sweden 25 and in 2014 in the United States.…”
Section: Discussionmentioning
confidence: 99%
“…21 While prescribers may view these so-called weak opioids as safer alternatives, data suggests that both codeine and tramadol have the potential for misuse and life-threatening adverse effects. 22,23,24 A possible explanation for these differences in prescribing is that, during the study period, low-dose codeine was available over the counter in Canada. Further, tramadol is still not considered a controlled or scheduled substance in Canada; however, it became a controlled substance in 2007 in Sweden 25 and in 2014 in the United States.…”
Section: Discussionmentioning
confidence: 99%
“…With patient consent, education should be provided to family as well, advising them of the signs and symptoms to look for as their loved one begins taking these medications. Additionally, patients using a prescribed controlled substance for a set period of time, such as three months, must attend a mandatory educational session with their healthcare provider before a new prescription is issued [29].…”
Section: Prevention and Educationmentioning
confidence: 99%
“…[6][7][8] While codeine is often considered to be less potent than other opioids, some of the adverse effects associated with its short-and long-term use include constipation, nausea, vomiting, respiratory depression, cognitive impairment; and a risk for substance addiction, misuse, and abuse. 9,10 Individual variability with codeine metabolism due to genetic polymorphism affecting cytochrome P-450 2D6 impacts the risk for experiencing these adverse effects (e.g., those who are rapid metabolizers may be at an increased risk, as they will be exposed to higher levels of morphine). 2,11 Opioids, including codeine and other morphine derivatives, are regulated as Schedule I drugs by Health Canada's Controlled Drugs and Substances Act.…”
Section: Context and Policy Issuesmentioning
confidence: 99%